Kisunla Injection, Solution
Product Images NDC 0002-9401

4 FDA label images from Eli Lilly And Company · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Kisunla (NDC 0002-9401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Kisunla Uspi F1 V1)

Figure 1 (Kisunla Uspi F1 V1)
A line graph comparing the least squares mean change in amyloid levels (expressed as SUVR on the left y-axis and Centiloids on the right y-axis) over 76 weeks between Kisunla (donanemab-azbt) and placebo. Kisunla shows a marked decrease in amyloid from baseline to week 76, while placebo remains near zero. Participant numbers at different time points are shown below the x-axis.*
FDA Label Image

Figure 2 (Kisunla Uspi F2 V1)

Figure 2 (Kisunla Uspi F2 V1)
A line graph comparing the least squares (LS) mean change in CDR-SB scores over 76 weeks between Kisunla and placebo groups. The x-axis shows weeks from 0 to 76, and the y-axis shows LS mean change with standard error. Kisunla shows less decline than placebo. Participant numbers for each group at several time points are listed below the graph.*
FDA Label Image

Package Label – Kisunla 350 mg Vial (Kisunla 350mg Carton 048 01)

Package Label – Kisunla 350 mg Vial (Kisunla 350mg Carton 048 01)
Kisunla 350 mg/20 mL (17.5 mg/mL) injection carton label for donanemab-azbt. The label displays the brand and generic names, dosage strength, and Eli Lilly and Company as the labeler. It includes storage instructions, dosage form as an intravenous solution, and a barcode with NDC 0002-9401-01. The packaging is primarily white with orange and gray text accents.*
FDA Label Image

Package Label – Kisunla 350 mg Vial (Kisunla 350mg Carton 052 01)

Package Label – Kisunla 350 mg Vial (Kisunla 350mg Carton 052 01)
Kisunla (donanemab-azbt) injection 350 mg/20 mL (17.5 mg/mL) carton label for intravenous use. The label includes storage instructions, dosage guidance referring to prescribing information, and contents details. Manufactured by Eli Lilly and Company, Indianapolis, IN, with product origin in South Korea. Single-dose vial indicated, accompanied by the Lilly logo and product NDC 0002-9401-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.